Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study

BACKGROUND: The optimal chemotherapeutics of recurrent disseminated glioblastoma has yet to be determined. We analyzed the efficacy and safety of recombinant human endostatin (rh-ES) combined with temozolomide and irinotecan in patients with recurrent disseminated glioblastoma. METHODS: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jing-jing, Li, Cheng, Qi, Shao-pei, Xue, Feng-jun, Gao, Zhi-meng, Yu, Chun-jiang, Zhang, Jun-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950828/
https://www.ncbi.nlm.nih.gov/pubmed/31914946
http://dx.doi.org/10.1186/s12885-019-6467-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950828/
https://www.ncbi.nlm.nih.gov/pubmed/31914946
http://dx.doi.org/10.1186/s12885-019-6467-6

Ejemplares similares